CDC Awards Pfizer $1.2 Billion for More COVID Vaccines: SAM.gov

0
601

by Jon Fleetwood, Jon Fleetwood:

The Centers for Disease Control and Prevention (CDC) awarded Pfizer more than $1.24 billion in contracts for adult and pediatric COVID-19 vaccines for fiscal years 2026 and 2027, according to federal procurement records published this month.

The awards were issued June 1 through the CDC Office of Acquisition Services.

The pediatric vaccine contract, identified as award number 75D30126D21001, carries a total value of $735,720,598.

TRUTH LIVES on at https://sgtreport.tv/

The adult vaccine contract, identified as award number 75D30126D21004, carries a total value of $505,272,000.

Both awards were issued to Pfizer and published on SAM.gov on June 3.

Donate

Share


One of the most striking aspects of the awards is that the pediatric contract exceeds the adult contract by more than $230 million, despite children generally facing substantially lower risk from COVID-19 than older adults.

Moreover, Pfizer’s COVID vaccine for children is over $100 less expensive than its adult jab, raising questions about the projected volume of pediatric doses the CDC expects to purchase—and why demand among children would justify a contract substantially larger than the one for adults.

The procurement records provide virtually no explanation for the spending.

The contract descriptions are blank.

No information is provided regarding projected dose quantities, expected demand, effectiveness data, safety considerations, or the rationale for allocating more than $1.24 billion in taxpayer funds toward COVID-19 vaccine purchases over the next two fiscal years.

The awards also suggest that federal COVID vaccine procurement remains a major government priority years after officials declared the emergency phase of the pandemic over and repeatedly characterized COVID-19 as an endemic respiratory virus.

Read More @ jonfleetwood.substack.com